This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Labopharm, China Direct: Early Volume Plays

NEW YORK (TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Friday's session.

Labopharm (DDSS) was indicated to trade sharply lower Friday after the specialty pharmaceutical company said it has commenced an offering of up to $20 million of units, which each unit consisting of one common share and a warrant to purchase a portion of a common share. The 50-day average daily volume for Labopharm is 1.72 million, according to the Nasdaq. Shares closed Thursday at $2.01 and were down more than 15% in the after-market session.

China Direct Industries (CDII) should also trade lower after the Chinese basic materials and consulting company posted an adjusted first-quarter loss of 3 cents a share as revenue dropped 43% from a year ago to $22.3 million. Looking ahead to the full-year, China Direct said it continues to see its net income ranging between $8 million and $10 million on revenue ranging from between $130 million and $150 million. The 50-day average daily volume for China Direct is 1.27 million. The stock finished Thursday at $1.74 before slipping 3.5% in late trading.

Rainmaker Systems (RMKR) was also poised to lose ground after the sales and marketing software company offered weak guidance for 2010 as it has been notified by Oracle (ORCL) that some of the programs it currently performs for Sun Microsystems will not be continued past Feb. 28. These programs accounted for approximately 13% of Rainmaker's fiscal 2009 annual revenue and 21% of fourth-quarter revenue. The 50-day average daily volume for Rainmaker is 23,000. Shares closed Thursday at $1.56 and fell nearly 15% in the after-market session.

NeoStem (NBS) is also poised to fall during Friday's session after the stem cell collection company priced a 5 million common stock offering at $1.35 a share, which is below Thursday's closing price of $1.62 a share. The three-month average daily volume for NeoStem is 70,000, according to Yahoo! Finance.

-- Written by Robert Holmes in Boston.

Check out all of Friday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,840.48 -145.13 -0.85%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs